SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028526
Filing Date
2018-11-08
Accepted
2018-11-08 16:02:58
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20180930.htm 10-Q 2284640
2 EX-10.1 spro-ex101_390.htm EX-10.1 1139286
3 EX-31.1 spro-ex311_7.htm EX-31.1 18292
4 EX-31.2 spro-ex312_9.htm EX-31.2 18488
5 EX-32.1 spro-ex321_6.htm EX-32.1 9823
6 EX-32.2 spro-ex322_8.htm EX-32.2 9840
7 GRAPHIC g1nb5ybxzhzn000010.jpg GRAPHIC 63728
8 GRAPHIC g1nb5ybxzhzn000009.jpg GRAPHIC 73464
9 GRAPHIC g1nb5ybxzhzn000011.jpg GRAPHIC 13707
10 GRAPHIC g1nb5ybxzhzn000004.jpg GRAPHIC 3181
11 GRAPHIC g1nb5ybxzhzn000005.jpg GRAPHIC 1582
12 GRAPHIC g1nb5ybxzhzn000001.jpg GRAPHIC 780
13 GRAPHIC g1nb5ybxzhzn000003.jpg GRAPHIC 752
14 GRAPHIC g1nb5ybxzhzn000006.jpg GRAPHIC 3574
15 GRAPHIC g1nb5ybxzhzn000008.jpg GRAPHIC 89132
16 GRAPHIC g1nb5ybxzhzn000007.jpg GRAPHIC 101148
17 GRAPHIC g1nb5ybxzhzn000002.jpg GRAPHIC 900
  Complete submission text file 0001564590-18-028526.txt   8895493

Data Files

Seq Description Document Type Size
18 XBRL INSTANCE DOCUMENT spro-20180930.xml EX-101.INS 1367500
19 XBRL TAXONOMY EXTENSION SCHEMA spro-20180930.xsd EX-101.SCH 58745
20 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20180930_cal.xml EX-101.CAL 48025
21 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20180930_def.xml EX-101.DEF 231875
22 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20180930_lab.xml EX-101.LAB 398583
23 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20180930_pre.xml EX-101.PRE 338613
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 181169616
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences